# Zentalis Pharmaceuticals, Inc.: Form 8-K/A, filed Dec 19, 2024

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: 8-K/A
- Filed: 2024-12-19
- Accepted by EDGAR: Dec 19, 2024, 16:01 ET
- Period: 2024-12-17
- Accession: 0001725160-24-000193
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000172516024000193/zntl-20241217.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000172516024000193/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000172516024000193/zntl-20241217.htm

Filed Dec 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001725160-24-000193. Last ingested by Listed: Nov 10, 2026, 02:14 ET. No prices; not investment advice.
